ImmunologybioRxivPreprint
Development and validation of IMMUNO-COV: a high-throughput clinical assay for detecting antibodies that neutralize SARS-CoV-2
R. Vandergaast, T. Carey, S. Reiter…·S. J. Russell
The paper develops and validates IMMUNO-COV, a high-throughput assay that accurately quantifies SARS-CoV-2-neutralizing antibodies in human sera.
DOI 10.1101/2020.05.26.117549